OR2C1
geneOn this page
Also known as OLFmf3
Summary
OR2C1 (olfactory receptor family 2 subfamily C member 1, HGNC:8242) is a protein-coding gene on chromosome 16p13.3, encoding Olfactory receptor 2C1 (O95371). Olfactory receptor that is activated by the binding of organosulfur odorants with thioether groups such as (methylthio)methanetiol (MTMT).
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 4993 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 45 total
- MANE Select transcript:
NM_012368
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:8242 |
| Approved symbol | OR2C1 |
| Name | olfactory receptor family 2 subfamily C member 1 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OLFmf3 |
| Ensembl gene | ENSG00000168158 |
| Ensembl biotype | protein_coding |
| Entrez | 4993 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000304936
RefSeq mRNA: 1 — MANE Select: NM_012368
NM_012368
CCDS: CCDS10502
Canonical transcript exons
ENST00000304936 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001160302 | 3355889 | 3357306 |
Expression profiles
Bgee: expression breadth broad, 34 present calls, max score 67.33.
Top tissues by expression
215 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 67.33 | silver quality |
| pancreatic ductal cell | CL:0002079 | 64.05 | silver quality |
| ileal mucosa | UBERON:0000331 | 59.76 | gold quality |
| buccal mucosa cell | CL:0002336 | 57.04 | gold quality |
| deltoid | UBERON:0001476 | 56.67 | silver quality |
| decidua | UBERON:0002450 | 56.55 | gold quality |
| hair follicle | UBERON:0002073 | 52.43 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 51.90 | gold quality |
| quadriceps femoris | UBERON:0001377 | 49.59 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| ventricular zone | UBERON:0003053 | 48.45 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.40 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.25 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.19 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| cortical plate | UBERON:0005343 | 47.82 | silver quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| metanephric glomerulus | UBERON:0004736 | 47.45 | gold quality |
| thymus | UBERON:0002370 | 47.42 | gold quality |
| kidney epithelium | UBERON:0004819 | 47.39 | gold quality |
| nephron tubule | UBERON:0001231 | 47.30 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.30 |
Regulation
Is transcription factor: no
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2c1 | ENSMUSG00000059043 |
| rattus_norvegicus | Or2c1 | ENSRNOG00000091036 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310), OR2T10 (ENSG00000184022)
Protein
Protein identifiers
Olfactory receptor 2C1 — O95371 (reviewed: O95371)
Alternative names: OLFmf3, Olfactory receptor 2C2, Olfactory receptor OR16-1, Olfactory receptor OR16-2
All UniProt accessions (1): O95371
UniProt curated annotations — full annotation on UniProt →
Function. Olfactory receptor that is activated by the binding of organosulfur odorants with thioether groups such as (methylthio)methanetiol (MTMT). Also binds odorants acetophenone and benzaldehyde. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. May be involved in the molecular processes underlying fasciculation and targeting of olfactory axons.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_036500* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (21 total): topological domain 8, transmembrane region 7, sequence variant 3, chain 1, glycosylation site 1, disulfide bond 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O95371-F1 | 82.69 | 0.42 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (1): 97–189
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381753 | Olfactory Signaling Pathway |
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 51 (showing top):
GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN, GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, BLALOCK_ALZHEIMERS_DISEASE_UP, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, LEE_AGING_CEREBELLUM_UP, TGGAAA_NFAT_Q4_01, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP, GOMF_ODORANT_BINDING, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, MIKKELSEN_ES_ICP_WITH_H3K4ME3
GO Biological Process (5): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception (GO:0050907)
GO Molecular Function (3): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984), odorant binding (GO:0005549)
GO Cellular Component (3): plasma membrane (GO:0005886), cell cortex (GO:0005938), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Sensory Perception | 1 |
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| sensory perception of chemical stimulus | 2 |
| transmembrane signaling receptor activity | 2 |
| cell periphery | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception | 1 |
| detection of chemical stimulus | 1 |
| detection of stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| binding | 1 |
| membrane | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
770 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2C1 | LITAFD | A0A1B0GVX0 | 623 |
| OR2C1 | RCBTB1 | Q8NDN9 | 460 |
| OR2C1 | OR51G1 | Q8NGK1 | 443 |
| OR2C1 | CDIP1 | Q9H305 | 440 |
| OR2C1 | H3BQ15 | H3BQ15 | 433 |
| OR2C1 | AMDHD2 | Q9Y303 | 423 |
| OR2C1 | OR2L13 | Q8N349 | 412 |
| OR2C1 | OR51G2 | Q8NGK0 | 411 |
| OR2C1 | OR4X1 | Q8NH49 | 407 |
| OR2C1 | TAS2R60 | P59551 | 406 |
| OR2C1 | OR4M1 | Q8NGD0 | 403 |
| OR2C1 | OR1J2 | Q8NGS2 | 400 |
| OR2C1 | OR52B2 | Q96RD2 | 396 |
| OR2C1 | NAA30 | Q147X3 | 392 |
| OR2C1 | CARHSP1 | Q9Y2V2 | 371 |
IntAct
0 interactions, top by confidence:
BioGRID (1): OR2C1 (Negative Genetic)
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O76099, O95006, O95047, O95371, P34982, P34984, P47884, P58170, Q15619, Q15622, Q5TZ20, Q60883, Q60887, Q60891, Q6IFH4, Q7Z3T1, Q8N628, Q8NG84, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA1, Q8NGA2, Q8NGQ5, Q8NGR9, Q8NGS1, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGW1, Q8NGX1, Q8NH06, Q8NH80, Q8NHA4, Q95157
Diamond homologs: A3KFT3, A4D2G3, A6NH00, A6NL26, A6NM03, O43869, O76000, O76001, O76002, O95006, O95221, O95371, O95918, P0C7N1, P0C7T2, P23274, P23275, P34984, P59922, Q13606, Q13607, Q5TZ20, Q60880, Q60890, Q6IEZ7, Q6IF00, Q8N127, Q8N349, Q8N628, Q8NG75, Q8NG76, Q8NG77, Q8NG80, Q8NG81, Q8NG83, Q8NG84, Q8NG85, Q8NG97, Q8NGC0, Q8NGE5
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
45 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 43 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
306 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:3356571:C:CG | donor_gain | 0.8500 |
| 16:3356779:T:A | acceptor_gain | 0.8400 |
| 16:3356826:G:GT | donor_gain | 0.8400 |
| 16:3356752:G:T | donor_gain | 0.7400 |
| 16:3356791:T:TA | acceptor_gain | 0.7400 |
| 16:3356863:G:GT | donor_gain | 0.7400 |
| 16:3356846:G:GT | donor_gain | 0.7300 |
| 16:3356564:A:AG | acceptor_gain | 0.7200 |
| 16:3356565:G:GG | acceptor_gain | 0.7200 |
| 16:3356571:C:G | donor_gain | 0.7100 |
| 16:3356696:T:G | acceptor_gain | 0.7000 |
| 16:3356677:T:A | acceptor_gain | 0.6800 |
| 16:3356695:AT:A | acceptor_gain | 0.6600 |
| 16:3356751:G:GT | donor_gain | 0.6500 |
| 16:3356611:C:T | donor_gain | 0.6200 |
| 16:3356708:C:G | donor_gain | 0.6200 |
| 16:3356638:G:T | donor_gain | 0.6100 |
| 16:3356696:T:TA | acceptor_gain | 0.6000 |
| 16:3356826:G:T | donor_gain | 0.6000 |
| 16:3356943:T:TA | acceptor_gain | 0.6000 |
| 16:3356656:A:AG | donor_gain | 0.5900 |
| 16:3356718:C:G | donor_gain | 0.5900 |
| 16:3356944:G:A | acceptor_gain | 0.5700 |
| 16:3356681:G:GG | donor_gain | 0.5600 |
| 16:3356682:G:GG | donor_gain | 0.5600 |
| 16:3356745:G:GT | donor_gain | 0.5600 |
| 16:3356859:A:T | donor_gain | 0.5600 |
| 16:3356529:G:GT | donor_gain | 0.5400 |
| 16:3356790:AT:A | acceptor_gain | 0.5300 |
| 16:3356829:G:GG | donor_gain | 0.5200 |
AlphaMissense
2014 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:3355974:T:C | F12L | 0.925 |
| 16:3355976:T:A | F12L | 0.925 |
| 16:3355976:T:G | F12L | 0.925 |
| 16:3356469:T:C | F177L | 0.890 |
| 16:3356471:C:A | F177L | 0.890 |
| 16:3356471:C:G | F177L | 0.890 |
| 16:3356691:T:C | F251L | 0.874 |
| 16:3356693:C:A | F251L | 0.874 |
| 16:3356693:C:G | F251L | 0.874 |
| 16:3356574:A:C | S212R | 0.868 |
| 16:3356576:C:A | S212R | 0.868 |
| 16:3356576:C:G | S212R | 0.868 |
| 16:3356166:A:C | S76R | 0.852 |
| 16:3356168:T:A | S76R | 0.852 |
| 16:3356168:T:G | S76R | 0.852 |
| 16:3356250:T:C | F104L | 0.848 |
| 16:3356252:C:A | F104L | 0.848 |
| 16:3356252:C:G | F104L | 0.848 |
| 16:3356157:T:C | F73L | 0.834 |
| 16:3356159:C:A | F73L | 0.834 |
| 16:3356159:C:G | F73L | 0.834 |
| 16:3356294:G:A | M118I | 0.833 |
| 16:3356294:G:C | M118I | 0.833 |
| 16:3356294:G:T | M118I | 0.833 |
| 16:3356305:G:C | R122P | 0.831 |
| 16:3356121:T:C | F61L | 0.829 |
| 16:3356123:C:A | F61L | 0.829 |
| 16:3356123:C:G | F61L | 0.829 |
| 16:3356124:T:C | F62L | 0.817 |
| 16:3356126:C:A | F62L | 0.817 |
dbSNP variants (sampled 300 via entrez): RS1000049602 (16:3338604 C>G), RS1000093859 (16:3340191 A>C), RS1000109638 (16:3338789 G>A), RS1000157817 (16:3335257 A>G), RS1000298536 (16:3354498 C>T), RS1000391810 (16:3345111 C>G), RS1000407948 (16:3328207 T>C), RS1000414182 (16:3356909 T>C,G), RS1000525551 (16:3328825 C>T), RS1000594689 (16:3331420 G>T), RS1000734700 (16:3322157 T>A,C), RS1000740959 (16:3324707 C>G,T), RS1000860031 (16:3358070 C>T), RS1001041978 (16:3336675 T>C), RS1001232917 (16:3344878 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004735_12 | Epstein-Barr virus copy number in lymphoblastoid cell lines | 2.000000e-07 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, increases methylation | 1 |
| hydroquinone | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Grape Seed Proanthocyanidins | affects cotreatment, decreases expression | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Catechin | affects cotreatment, decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Epstein-Barr virus infection